Cue Biopharma
CUE
CUE
75 hedge funds and large institutions have $17.1M invested in Cue Biopharma in 2024 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 14 increasing their positions, 22 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less ownership
Funds ownership: →
36% less repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 22
45% less capital invested
Capital invested by funds: $31M → $17.1M (-$13.9M)
Holders
75
Holding in Top 10
–
Calls
$279K
Puts
$18K
Top Buyers
| 1 | +$371K | |
| 2 | +$364K | |
| 3 | +$253K | |
| 4 |
Millennium Management
New York
|
+$217K |
| 5 |
BL
Bleichroeder LP
New York
|
+$176K |
Top Sellers
| 1 | -$2.45M | |
| 2 | -$961K | |
| 3 | -$571K | |
| 4 |
Renaissance Technologies
New York
|
-$518K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$415K |